Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF) Short Interest Up 320.4% in July

Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS:SBLOF) was the target of a large increase in short interest during the month of July. As of July 15th, there was short interest totaling 81,981 shares, an increase of 320.4% from the June 30th total of 19,501 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.

Shin Nippon Biomedical Laboratories Price Performance

Shares of Shin Nippon Biomedical Laboratories stock opened at $7.00 on Friday. Shin Nippon Biomedical Laboratories has a 12-month low of $7.00 and a 12-month high of $9.16. The stock has a 50 day moving average price of $7.69 and a two-hundred day moving average price of $9.01.

Shin Nippon Biomedical Laboratories Company Profile

Shin Nippon Biomedical Laboratories, Ltd. (OTCMKTS: SBLOF) is a Japan‐based contract research organization specializing in nonclinical safety assessment for the pharmaceutical, biotechnology and agrochemical industries. Established in 1978 and headquartered in Kagoshima, the company provides a range of preclinical testing services designed to support drug development from early discovery through regulatory submission. SBLOF is known for its adherence to Good Laboratory Practice (GLP) standards and its focus on high‐quality data generation and compliance.

The company’s core services include toxicology studies, pharmacokinetics and bioanalysis, safety pharmacology, pathology and genetic toxicology.